BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21790109)

  • 1. Optical coherence tomography in the diagnosis and management of optic neuritis and multiple sclerosis.
    Costello FE; Klistorner A; Kardon R
    Ophthalmic Surg Lasers Imaging; 2011 Jul; 42 Suppl():S28-40. PubMed ID: 21790109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
    Pueyo V; Martin J; Fernandez J; Almarcegui C; Ara J; Egea C; Pablo L; Honrubia F
    Mult Scler; 2008 Jun; 14(5):609-14. PubMed ID: 18424482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in optic neuritis related to multiple sclerosis.
    Chan JW
    Acta Ophthalmol; 2012 May; 90(3):203-9. PubMed ID: 21486394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis. Part I: neuro-ophthalmic manifestations.
    Pula JH; Reder AT
    Curr Opin Ophthalmol; 2009 Nov; 20(6):467-75. PubMed ID: 19809319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future potential of retinal optical coherence tomography in multiple sclerosis with and without optic neuritis.
    Balk LJ; Petzold A
    Neurodegener Dis Manag; 2014; 4(2):165-76. PubMed ID: 24832034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNFL thickness in MS-associated acute optic neuritis using SD-OCT: critical interpretation and limitations.
    Serbecic N; Beutelspacher SC; Geitzenauer W; Kircher K; Lassmann H; Reitner A; Khan A; Schmidt-Erfurth U
    Acta Ophthalmol; 2011 Aug; 89(5):e451-60. PubMed ID: 21401908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optic neuritis in multiple sclerosis: diagnosis and prognosis data].
    Beddiaf A; de Sèze J
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S145-7. PubMed ID: 19361679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of retinal nerve fiber layer and central macular thickness measurements among five different optical coherence tomography instruments in patients with multiple sclerosis and optic neuritis.
    Watson GM; Keltner JL; Chin EK; Harvey D; Nguyen A; Park SS
    J Neuroophthalmol; 2011 Jun; 31(2):110-6. PubMed ID: 21131852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis.
    Sergott RC
    Curr Opin Ophthalmol; 2005 Dec; 16(6):346-50. PubMed ID: 16264344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of optical coherence tomography in multiple sclerosis: expert panel consensus.
    Sergott RC; Frohman E; Glanzman R; Al-Sabbagh A;
    J Neurol Sci; 2007 Dec; 263(1-2):3-14. PubMed ID: 17673257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
    Fisher JB; Jacobs DA; Markowitz CE; Galetta SL; Volpe NJ; Nano-Schiavi ML; Baier ML; Frohman EM; Winslow H; Frohman TC; Calabresi PA; Maguire MG; Cutter GR; Balcer LJ
    Ophthalmology; 2006 Feb; 113(2):324-32. PubMed ID: 16406539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis and the ophthalmologist.
    Mowry EM; Balcer LJ; Galetta SL
    Compr Ophthalmol Update; 2007; 8(1):39-49. PubMed ID: 17394758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early factors associated with axonal loss after optic neuritis.
    Henderson AP; Altmann DR; Trip SA; Miszkiel KA; Schlottmann PG; Jones SJ; Garway-Heath DF; Plant GT; Miller DH
    Ann Neurol; 2011 Dec; 70(6):955-63. PubMed ID: 22190367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis.
    Lamirel C; Newman NJ; Biousse V
    Rev Neurol (Paris); 2010 Dec; 166(12):978-86. PubMed ID: 20605617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients.
    Garcia-Martin E; Pueyo V; Ara JR; Almarcegui C; Martin J; Pablo L; Dolz I; Sancho E; Fernandez FJ
    Mult Scler; 2011 Jul; 17(7):830-7. PubMed ID: 21300734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic neuritis.
    Toosy AT; Mason DF; Miller DH
    Lancet Neurol; 2014 Jan; 13(1):83-99. PubMed ID: 24331795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the use of optical coherence tomography in optic neuritis.
    Costello F
    Mult Scler Int; 2011; 2011():148394. PubMed ID: 22096626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving management of optic neuritis and multiple sclerosis.
    Arnold AC
    Am J Ophthalmol; 2005 Jun; 139(6):1101-8. PubMed ID: 15953446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.